Pharmadrug Inc.
PHRX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.60K | -14.60K | 23.20K | 15.30K | 271.50K |
| Depreciation & Amortization | 8.80K | 9.00K | 9.20K | 9.20K | 9.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.40K | 64.20K | 37.10K | 1.70K | 329.00K |
| Operating Income | -32.40K | -64.20K | -37.10K | -1.70K | -329.00K |
| Income Before Tax | -81.60K | -5.00K | -132.70K | -105.20K | -401.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -81.60K | -5.00K | -132.70K | -105.20K | -401.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.80K | 57.10K | -- | -- | 32.70K |
| Net Income | -69.80K | 52.00K | -132.70K | -105.20K | -368.60K |
| EBIT | -32.40K | -64.20K | -37.10K | -1.70K | -329.00K |
| EBITDA | -23.60K | -55.20K | -27.90K | 7.50K | -319.70K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 107.77M | 103.30M | 104.14M | 100.39M | 94.91M |
| Average Diluted Shares Outstanding | 107.77M | 103.30M | 104.14M | 100.39M | 94.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |